Retirement Systems of Alabama lessened its stake in shares of Agilent Technologies Inc (NYSE:A) by 2.1% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 147,002 shares of the medical research company’s stock after selling 3,170 shares during the quarter. Retirement Systems of Alabama’s holdings in Agilent Technologies were worth $10,370,000 at the end of the most recent reporting period.
Other hedge funds and other institutional investors also recently made changes to their positions in the company. Quantitative Systematic Strategies LLC lifted its holdings in shares of Agilent Technologies by 247.6% during the 2nd quarter. Quantitative Systematic Strategies LLC now owns 23,818 shares of the medical research company’s stock valued at $1,473,000 after purchasing an additional 16,966 shares during the last quarter. Paloma Partners Management Co lifted its holdings in shares of Agilent Technologies by 119.6% during the 2nd quarter. Paloma Partners Management Co now owns 26,924 shares of the medical research company’s stock valued at $1,665,000 after purchasing an additional 14,661 shares during the last quarter. Point72 Asset Management L.P. purchased a new stake in shares of Agilent Technologies during the 2nd quarter valued at $6,308,000. Harvey Investment Co. LLC purchased a new stake in shares of Agilent Technologies during the 2nd quarter valued at $5,742,000. Finally, MAI Capital Management purchased a new stake in shares of Agilent Technologies during the 2nd quarter valued at $394,000.
A number of equities analysts recently issued reports on A shares. ValuEngine lowered Agilent Technologies from a “buy” rating to a “hold” rating in a research note on Tuesday, October 23rd. Zacks Investment Research lowered Agilent Technologies from a “buy” rating to a “hold” rating in a research note on Tuesday, October 16th. Morgan Stanley raised their target price on Agilent Technologies from $84.00 to $86.00 and gave the stock an “overweight” rating in a research note on Wednesday, October 10th. Goldman Sachs Group restated a “buy” rating and issued a $82.00 target price (up previously from $77.00) on shares of Agilent Technologies in a research note on Tuesday, September 18th. Finally, Deutsche Bank raised their target price on Agilent Technologies from $77.00 to $80.00 and gave the stock a “buy” rating in a research note on Wednesday, August 15th. Two investment analysts have rated the stock with a hold rating and eight have issued a buy rating to the company. The company has an average rating of “Buy” and an average price target of $77.44.
Agilent Technologies (NYSE:A) last issued its earnings results on Tuesday, August 14th. The medical research company reported $0.67 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.63 by $0.04. The company had revenue of $1.20 billion during the quarter, compared to analyst estimates of $1.20 billion. Agilent Technologies had a return on equity of 18.61% and a net margin of 6.20%. The firm’s quarterly revenue was up 8.0% on a year-over-year basis. During the same quarter last year, the business posted $0.59 EPS. Analysts forecast that Agilent Technologies Inc will post 2.71 EPS for the current fiscal year.
The business also recently declared a quarterly dividend, which was paid on Wednesday, October 24th. Shareholders of record on Tuesday, October 2nd were given a dividend of $0.149 per share. This represents a $0.60 annualized dividend and a yield of 0.92%. The ex-dividend date of this dividend was Monday, October 1st. Agilent Technologies’s dividend payout ratio is currently 25.42%.
In other Agilent Technologies news, Director Paul N. Clark sold 2,876 shares of the stock in a transaction dated Thursday, September 13th. The stock was sold at an average price of $68.60, for a total transaction of $197,293.60. The sale was disclosed in a filing with the SEC, which is available through this link. Also, Director Heidi Fields sold 5,482 shares of the stock in a transaction dated Tuesday, September 11th. The stock was sold at an average price of $67.73, for a total value of $371,295.86. The disclosure for this sale can be found here.
Agilent Technologies Profile
Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. It operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; microfluidics based automated electrophoresis products; cell analysis plate based assays; laboratory software and informatics systems; laboratory automation; dissolution testing; vacuum pumps; and measurement technologies.
Recommended Story: Return on Investment (ROI) Defined, Explained
Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies Inc (NYSE:A).
Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.